SARCOMA
Clinical trials for SARCOMA explained in plain language.
Never miss a new study
Get alerted when new SARCOMA trials appear
Sign up with your email to follow new studies for SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough cancers: experimental drug enters first human tests
Disease control Not yet recruitingThis is a very early study to find the safest dose of a new drug called 177Lu-INN805 for people with advanced solid tumors that haven't responded to standard treatments. It will enroll about 10 patients with cancers like head & neck, lung, breast, or sarcoma to test how the body …
Matched conditions: SARCOMA
Phase: EARLY_PHASE1 • Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Gene-Edited 'Living Drug' trial seeks to reboot immune system against tough cancers
Disease control Not yet recruitingThis is an early safety study for people with advanced lymphoma, myeloma, or certain solid tumors (like kidney cancer and sarcoma) that have come back after standard treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to recognize and a…
Matched conditions: SARCOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug combo tested for Tough-to-Treat sarcomas
Disease control Not yet recruitingThis early-stage trial aims to find a safe dose of a new drug called BOLD-100 when given with standard chemotherapy (doxorubicin) for advanced soft tissue sarcoma. It will enroll about 32 adults who haven't had prior treatment for their advanced disease. The main goal is to check…
Matched conditions: SARCOMA
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New program aims to guide young cancer survivors through critical Follow-Up care
Disease control Not yet recruitingThis study is creating and testing a patient navigation program to help young adults who have survived cancer. The program aims to guide survivors to get the recommended primary care and cancer check-ups they need. Researchers will first adapt an existing program for young surviv…
Matched conditions: SARCOMA
Phase: NA • Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
New hope for Tough-to-Treat sarcomas: Triple-Drug attack enters testing
Disease control Not yet recruitingThis study is testing a new combination of three drugs (selumetinib, ZEN-3694, and durvalumab) for people with advanced sarcomas that have not responded to standard treatments. The first part of the trial will find safe doses, and the second part will focus on a specific, aggress…
Matched conditions: SARCOMA
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC
-
Glowing dye trial aims to guide surgeons in delicate pediatric cancer operations
Diagnosis Not yet recruitingThis study is testing whether a special green dye can safely and effectively help surgeons see the first lymph nodes that cancer might spread to in children with solid tumors. During surgery, the dye is injected near the tumor and glows under a special camera, highlighting these …
Matched conditions: SARCOMA
Phase: PHASE1 • Sponsor: University of Rochester • Aim: Diagnosis
Last updated Mar 31, 2026 12:10 UTC
-
Cancer treatment side effects linked to drug Mix-Ups?
Knowledge-focused Not yet recruitingThis study aims to understand why cancer immunotherapy drugs sometimes cause serious side effects. Researchers suspect these drugs might change how the liver processes other medications patients are taking. The study will give 80 cancer patients a special cocktail of safe test dr…
Matched conditions: SARCOMA
Phase: EARLY_PHASE1 • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC